biomedicina slovenica

pr=Ciuleanu : 9

1. Janžič Urška; Turnšek Nina; Dediu Mircea; Shterev Donev Ivan; Lupu Roxana; Teodorescu Gabriela; Ciuleanu Tudor; Płużański Adam
   Real-world testing practices, treatment patterns and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced non-small cell lung cancer
   2022 ►
2. Addeo Alfredo; Hochmair Maximilian J; Janžič Urška; Dudnik Elizabeth; Charpidou Andriani; Płużański Adam; Ciuleanu Tudor; Shterev Donev Ivan; Elbaz Judith; Aar J; Ott René; Peled Nir
   Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC
   e
   rgen
   2021 ►
3. Zemanova Milada; Jakopović Marko; Stanič Karmen; Łazar-Poniatowska Małgorzata; Vrankar Martina; Rusu Petronela; Ciuleanu Tudor; Radosavljevic Davorin; Bogos Krisztina; Nawrocki Sergiusz
   Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe
   2020 ►
4. Čufer Tanja; Ciuleanu Tudor; Berzinec Peter; Galffy Gabriela; Jakopović Marko; Jassem Jacek; Jovanovic Dragana; MIhaylova Zhasmina; Ostoros Gyula; Thallinger Christiane; Zemanova Milada; Zielinski Christoph
   Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe
   2020 ►
5. Ciuleanu Tudor; Scheithauer W.; Kurteva G.; Ocvirk Janja; Koza I.; Papamichael D.; Wenczl M.; Brodowicz Thomas; Beslija Semir; Zielinski Christoph C.
   A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
   2008 ►
6. Ciuleanu Tudor; Ocvirk Janja
   A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
   2008 ►
7. Ciuleanu Tudor; Ocvirk Janja
   A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer
   2007 ►
8. Vrdoljak Eduard; Ciuleanu Tudor; Kharkevich Galina; Mardiak Jozef; Mego Michal; Padrik Peeter; Petruželka Luboš; Purkalne Gunta; Shparyk Yaroslav; Škrbinc Breda; Szczylik Cezary; Torday Laszlo
   Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region
   2012 ►
9. Peterson P.; Zwitter Matjaž; Krzakowski Maciej; Wenczl M.; Tzekova V.; Ramlau R.; Ciuleanu T.; Liepa A.; Zielinski C.; Brodowicz Thomas
   Delay in time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC) using gemcitabine (gem) maintenance therapy
   2006 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics